ARHGAP10 is well known as a tumor suppressor and has been demonstrated in a variety of cancers, such as Uterine leiomyomas (ULs), prostate cancer, ovarian cancer (OC), lung cancer, colon carcinoma (CRC) and BC [33–38]. Here, ARHGAP10 is linked to colorectal carcinoma.